title: [Combined treatment of genital human papillomavirus infection in men].
abstract: This study aimed to assess the efficacy of treatment of genital human papillomavirus infection in 107 men. Patients in group 1 (n=51) underwent laser ablation of genital warts, patients in group 2 (n=56) were treated with laser ablation in conjunction with the administration of an immune system medication izoprinozin. During the first 9 months post-treatment, human papillomavirus infection relapse rate in group 1 was 23,5% and in group 2 - 5,4%. It was likewise observed that the combined treatment of genital warts resulted in reduced incidence of infective complications and the time of wound epithelialization after laser papilloma ablation.
authors.affiliation: Department of Urology, First Pavlov State Medical University, St. Peterburg.|Department of Urology, Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical University, St. Peterburg.
authors.forename: S H
authors.initials: SH
authors.lastname: Al'-Shukri
authors.affiliation: Department of Urology, First Pavlov State Medical University, St. Peterburg.|Department of Urology, Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical University, St. Peterburg.
authors.forename: I V
authors.initials: IV
authors.lastname: Kuz'min
authors.affiliation: Department of Urology, Scientific Research Institute of Surgery and Emergency Medicine, First Pavlov State Medical University, St. Peterburg.
authors.forename: M N
authors.initials: MN
authors.lastname: Slesarevskaya
mesh_terms: D003131:Combined Modality Therapy; D003218:Condylomata Acuminata / Q000628:therapy; D005835:Genitalia / Q000821:virology; D006801:Humans; D015994:Incidence; D008297:Male; D030361:Papillomavirus Infections / Q000628:therapy
keywords: genital papilloma; izoprinozin; laser ablation; papilloma infection